Taylor S Cohen Selected Research

Thrombocytopenia (Thrombopenia)

1/2022	Serum levels of anti-PF4 IgG after AZD1222 (ChAdOx1 nCoV-19) vaccination.
12/2021	ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Taylor S Cohen Research Topics

Disease

11	Infections 01/2022 - 01/2013
7	Pneumonia (Pneumonitis) 01/2021 - 01/2012
4	Inflammation (Inflammations) 01/2019 - 06/2011
4	Sepsis (Septicemia) 01/2018 - 06/2010
3	Alcoholic Fatty Liver 01/2023 - 09/2019
2	COVID-19 03/2024 - 02/2024
2	Body Weight (Weight, Body) 03/2024 - 01/2023
2	Fatty Liver 01/2023 - 01/2020
2	Thrombosis (Thrombus) 01/2022 - 12/2021
2	Thrombocytopenia (Thrombopenia) 01/2022 - 12/2021
2	Bacterial Infections (Bacterial Infection) 01/2020 - 01/2016
2	Superinfection 01/2019 - 02/2016
2	Coinfection 02/2016 - 01/2016
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Human Influenza (Influenza) 01/2019
1	Surgical Wound Infection 01/2019
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2019
1	Rheumatoid Arthritis 10/2018
1	Persistent Infection 01/2018
1	Infectious Arthritis (Septic Arthritis) 01/2017
1	Osteomyelitis 01/2017
1	Respiratory Tract Infections (Respiratory Tract Infection) 02/2016
1	Virus Diseases (Viral Diseases) 01/2016
1	Cystic Fibrosis (Mucoviscidosis) 01/2012
1	Wounds and Injuries (Trauma) 06/2011

Drug/Important Bio-Agent (IBA)

5	Monoclonal AntibodiesIBA 02/2024 - 01/2017
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 01/2017
2	cilgavimab and tixagevimab drug combinationIBA 03/2024 - 02/2024
2	tixagevimabIBA 03/2024 - 02/2024
2	AntibodiesIBA 03/2024 - 05/2017
2	cilgavimabIBA 03/2024 - 02/2024
2	EndotoxinsIBA 01/2020 - 02/2014
2	TitaniumIBA 01/2018 - 01/2017
2	InflammasomesIBA 01/2018 - 04/2013
2	Interferon LambdaIBA 02/2016 - 01/2016
1	SpermidineIBA 01/2023
1	PolyaminesIBA 01/2023
1	Drinking WaterIBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	ChAdOx1 nCoV-19IBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	Heparin (Liquaemin)FDA LinkGeneric 12/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Insulin (Novolin)FDA Link 01/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020
1	Dietary Fats (Dietary Fat)IBA 09/2019
1	Islet Amyloid PolypeptideIBA 09/2019
1	LeptinIBA 09/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2019
1	p38 Mitogen-Activated Protein KinasesIBA 01/2019
1	suvratoxumabIBA 01/2019
1	MEDI8852IBA 01/2019
1	Secretory Proteinase Inhibitory ProteinsIBA 12/2018
1	FlagellinIBA 12/2018
1	sivelestatIBA 12/2018
1	Toll-Like Receptor 5IBA 12/2018
1	Protein-Arginine DeiminasesIBA 10/2018
1	AutoantigensIBA 10/2018
1	Proteins (Proteins, Gene)FDA Link 10/2018
1	Hemolysin Proteins (Hemolysins)IBA 01/2018
1	Immune Sera (Antisera)IBA 05/2017
1	salicylhydroxamic acid (SHAM)IBA 01/2017
1	factor AIBA 01/2017
1	Virulence Factors (Pathogenicity Factors)IBA 03/2016
1	InterferonsIBA 02/2016
1	Interleukin-22 (IL-22)IBA 02/2016
1	LipopolysaccharidesIBA 02/2014
1	Interleukin-18 (Interleukin 18)IBA 04/2013
1	CytokinesIBA 01/2013
1	Interferon Type IIBA 01/2012
1	Poly I-CIBA 01/2012
1	GelsolinIBA 06/2011
1	pyrazolanthroneIBA 06/2010
1	U 0126 (UO 126)IBA 06/2010

Therapy/Procedure

2	Therapeutics 03/2024 - 01/2021
1	Prostheses and Implants (Prosthesis) 01/2018
1	Ligation 06/2011
1	Punctures 06/2011